26978042|t|Telomere shortening leads to earlier age of onset in ALS mice.
26978042|a|Telomere shortening has been linked to a variety of neurodegenerative diseases. Recent evidence suggests that reduced telomerase expression results in shorter telomeres in leukocytes from sporadic patients with amyotrophic lateral sclerosis (ALS) compared with healthy controls. Here, we have characterized telomere length in microglia, astroglia and neurons in human post mortem brain tissue from ALS patients and healthy controls. Moreover, we studied the consequences of telomerase deletion in a genetic mouse model for ALS. We found a trend towards longer telomeres in microglia in the brains of ALS patients compared to non-neurologic controls. Knockout of telomerase leading to telomere shortening accelerated the ALS phenotype inSOD1G93A-transgenic mice. Our results suggest that telomerase dysfunction might contribute to the age-related risk for ALS. 
26978042	53	56	ALS	Disease	MESH:D000690
26978042	57	61	mice	Species	10090
26978042	115	141	neurodegenerative diseases	Disease	MESH:D019636
26978042	260	268	patients	Species	9606
26978042	274	303	amyotrophic lateral sclerosis	Disease	MESH:D000690
26978042	305	308	ALS	Disease	MESH:D000690
26978042	425	430	human	Species	9606
26978042	461	464	ALS	Disease	MESH:D000690
26978042	465	473	patients	Species	9606
26978042	570	575	mouse	Species	10090
26978042	586	589	ALS	Disease	MESH:D000690
26978042	663	666	ALS	Disease	MESH:D000690
26978042	667	675	patients	Species	9606
26978042	783	786	ALS	Disease	MESH:D000690
26978042	819	823	mice	Species	10090
26978042	850	860	telomerase	Disease	
26978042	918	921	ALS	Disease	MESH:D000690

